Updated Treatment of Fibromyalgia Syndrome: A Review
Ahmed Abdulaziz G. Ibrahim, Mazyad Hamed M. AlMutairi, Abeer Fahad M. ALMutairi, Wejdan Alhumaidi A. Alharbi, Ebtesam Ali S. Almadi, Shoog Abdullah O. Alwabisi, Nashwa Zead A. Albalawi, Hamdah Hnef S. Alanazi, ALanoud Abdullah H. Althobaiti, Amirah Ali M. Alkhathami, Amani Salem K. Alamrani, Omniah Salem D. Altemani, Maani Mahmoud A. Mohammedsaleh, Arwa Mohammed Alrefai Aljuhani, Rinad Rasheed M Alrashidi
Journal of Pharmaceutical Research International · pp. 72–79 · Published 1 Dec 2021
10.9734/jpri/2021/v33i52B33601Abstract
Fibromyalgia is a debilitating condition that is frequently misdiagnosed. It affects 2% of the population, with middle-aged women having the highest frequency. Fibromyalgia affects more women than men, and It becomes worse as you get older. Because medical treatment for fibromyalgia is typically only partial, health professionals must provide patients with ongoing assistance in order for them to become effective, active self-managers. There is no one-size-fits-all drug for fibromyalgia, but you do have a lot of options for treating your symptoms. However, Antidepressants in general such as “duloxetine” and Gabapentinoids drugs such as “pregabline” are the most used drugs. There is some evidence that NSAIDs may have a synergistic effect when combined with centrally active agents such as tricyclic antidepressants and anticonvulsants. Among non-pharmacological therapy, exercise and psychoeducational techniques have the most evidence of efficacy, but they must be personalized to the individual. In this review we will be looking at diagnosis and treatment of fibromyalgia.
Cited by 1
Khawaja Faizan Ejaz, Rehan Wani, Amna Akbar · Cureus · 2024
Related research
- The Nature and Complications of Acute Traumatic Cervical Spinal Cord Injury in a University Hospital in Nigeria — shares topic coverage
- Risk Factors Assessment of Zoonotic Anthrax among the People at Risk (PAR) in Selected Areas of Bangladesh — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Systematic Review of Visceral Leishmaniasis in Central Africa — shares topic coverage
- Administration of High-Risk Medication: A Hospital Based Prospective Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.